HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

JNJ-26483327

an orally active macrocyclic tyrosine kinase inhibitor for treatment of patients with advanced solid tumours; in Phase I trial, 9/2010
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Yuan, Z: 1 article (09/2010)
2. van der Gaast, A: 1 article (09/2010)
3. Eskens, F A L M: 1 article (09/2010)
4. Hellemans, P: 1 article (09/2010)
5. Verweij, J: 1 article (09/2010)
6. Burger, H: 1 article (09/2010)
7. van Beijsterveldt, L E C: 1 article (09/2010)
8. Winkler, H: 1 article (09/2010)
9. Konings, I R H M: 1 article (09/2010)
10. de Jonge, M J A: 1 article (09/2010)

Related Diseases

1. Vomiting
2. Neoplasms (Cancer)
3. Nausea
4. Fatigue
5. Exanthema (Rash)